BSE NSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Natco Pharma Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524816
ISIN Demat
INE987B01026
Book Value (Rs)
409.4649822
NSE Symbol
NATCOPHARM
Divident Yield %
0.59
Market Cap
(Rs In Cr.)
18,221
P/E (TTM)
9.85
EPS (TTM)
103.31
Face Value
(Rs)
2
Back
Natco Pharma Ltd - Natco Pharma Limited - Retirement
30-Jun-25   Hrs IST

Natco Pharma Limited has informed the Exchange about Superannuation of Dr. Muddasaani Pulla Reddy, Executive Vice President - R & D and Mr. CH Srinivas, Senior Vice President Demand & Supply and also Resignation of Mr. R. Sridhar Reddy Senior Vice President GCQA with effect from the closure of business hours on 30th June, 2025

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)